The efficacy and safety of dual HER2 blockade with a pertuzumab-based regimen for metastatic breast cancer patients previously exposed to an anti-HER2 agent: a systematic review and meta-analysis

Bibliographic Details
Main Authors: S. Chen, X. Sun, B. Liu, Y. Gao, Y. Yang, W. Cao, F. Ma
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621001478